Primary prevention of acute myocardial infarction with aspirin
Agustí, Aònia.; Diogène, E.
Medicina Clinica 122(15): 592-594
2004
ISSN/ISBN: 0025-7753 PMID: 15144749 Document Number: 579457
Document emailed within 1 workday
Related Documents
Young, F.E.; Nightingale, S.L.; Temple, R.A. 1988: The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction JAMA 259(21): 3158-31601980: The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group Circulation 62(6 Pt 2): V79-V84
Madsen, J.K.; Pedersen, F.; Amtoft, A.; Deding, A.; Grande, P.; Hansen, J.N.; Hilden, M.; Hornum, I.; Jensen, T.; Lindskov, J. 1989: Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2 Ugeskrift for Laeger 151(40): 2565-2569
Luo, Y. 1993: Improvement of prostacyclin-thromboxane A2 balance in patients with acute myocardial infarction by intermittent aspirin Zhonghua Xin Xue Guan Bing Za Zhi 21(4): 219
Wang, Y.Y.; Li, T.; Liu, Y.W.; Liu, B.J.; Hu, X.M.; Wang, Y.; Gao, W.Q.; Wu, P.; Huang, L.; Li, X.; Peng, W.J.; Ning, M. 2017: Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 45(4): 277-282
Zhang, Y-chen.; Jia, S-qing.; Wang, L.; Li, H-wei. 2006: The relationship between high sensitivity C-reactive protein level at admission and myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction Zhonghua Xin Xue Guan Bing Za Zhi 34(5): 422-424
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Mehta, R.H.; Eagle, K.A. 1998: Secondary prevention in acute myocardial infarction Bmj 316(7134): 838-842
Bräutigam, M.; Grip, L.; Hartford, M.; Karlsson, T.; Svensson, L.; Herlitz, J. 2001: Primary PTCA or thrombolysis in acute myocardial infarction? Lakartidningen 98(32-33): 3392-3395
Magalski, A.; O'Keefe, J.H. 1997: Thrombolysis or primary angioplasty for acute myocardial infarction? New England Journal of Medicine 336(15): 1101-1102; Author Reply 1102-1103
Willenheimer, R.; Erhardt, L.; Eskilsson, J. 1998: Heart failure after myocardial infarction: diagnosis, treatment, prevention. Echocardiography should be a routine procedure in myocardial infarction Lakartidningen 95(28-29): 3183-3187
Tatu-Chiţoiu, G.; Teodorescu, C.; Dan, M.; Guran, M.; Căpraru, P.; Istrăţescu, O.; Tatu-Chiţoiu, A.; Bumbu, A.; Chioncel, V.; Arvanitopol, S.; Dorobanţu, M. 2004: Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. a substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA) Romanian Journal of Internal Medicine 42(3): 557-573
Hansen, J.F.; Mellemgaard, K. 1992: Drugs for the prevention of death and recurrence after acute myocardial infarction Ugeskrift for Laeger 154(7): 397
Beygui, F. 2000: Trimetazidine as adjunctive therapy to primary PTCA for acute myocardial infarction Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 19(Suppl 5): V31-V34
Halvorsen, S.; Myhre, K.I.; Steigen, T.; Nordrehaug, J.E.; Gundersen, T.; Wiseth, R. 2003: Primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(2): 152-155
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Prerovský, I.; Niederle, P.; Simonová, J.; Kapitola, J. 1988: Deep vein thrombosis and its prevention in patients with acute myocardial infarction Cor et Vasa 30(5): 345-351
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Cervinka, P.; Spacek, R.; Bystron, M.; Kvasnák, M.; Behounek, M.; Bednárová, J.; Herman, J.; Veselka, J. 2005: Distal protection during primary coronary angioplasty in patients with acute myocardial infarction Casopis Lekaru Ceskych 144(5): 315-319
Thelle, D.S. 1988: Aspirin and myocardial infarction--a gimmick from the media? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(13): 1055-1056